newsfilter
← Latest News
Business Wire·

Celyad Oncology Reports First Half Year 2026 Results

Regulatory News: Celyad Oncology (Euronext: CYAD) ("Celyad" or the "Company"), today announced its financial results for the first half year 2026 ended June 30, 2026. First Half 2026 financial